This small biotech could grow much larger with some good news from its pipeline.

Iovance Biotherapeutics argues that there is a meaningful opportunity here of more than 8,000 patients diagnosed annually in ...

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

With an approved treatment in commercial stages and new drug candidates generating clinical trial results, this biotech has ...

In this article, we will look at the 12 Cheap Biotech Stocks to Buy Now. On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector. Last year ...

Stock Market Today: The Dow Jones fell on President Trump's latest Iran move. Software stocks and biotech shined but Goldman Sachs fell.

Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector's two major indexes - the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) - ...